The capability of the breast metastatic CD44−CD24+ cells isolated from bone to generate new heterogeneous tumors with a high percentage of CD44+CD24− CSCs is consistent with a phenotypic plasticity of these cells, that allow metastatic cells to regain a tumor-initiating capacity. This evidence concerns the gene CD44 and neoplasm.